Loading…
Abeona Therapeutics Inc. is projected to rise to $8.61 by 2027, a +23% move from its current price of $6.98. ABEO is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $6.80 | $6.98 | $7.17 | +0.02% |
| Jul 14 | $6.72 | $6.98 | $7.25 | +0.04% |
| Jul 15 | $6.67 | $6.98 | $7.32 | +0.07% |
| Jul 16 | $6.62 | $6.99 | $7.37 | +0.09% |
| Jul 17 | $6.58 | $6.99 | $7.42 | +0.11% |
| Jul 18 | $6.54 | $6.99 | $7.46 | +0.13% |
| Jul 19 | $6.51 | $6.99 | $7.51 | +0.16% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $6.51 | $6.99 | $7.51 | +0.16% |
| Week 2 | $6.33 | $7.00 | $7.74 | +0.31% |
| Week 3 | $6.20 | $7.01 | $7.93 | +0.47% |
| Week 4 | $6.09 | $7.02 | $8.09 | +0.62% |
| Week 5 | $6.00 | $7.03 | $8.24 | +0.78% |
| Week 6 | $5.92 | $7.05 | $8.38 | +0.94% |
| Week 7 | $5.85 | $7.06 | $8.51 | +1.10% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Abeona Therapeutics Inc. is a commercial-stage biopharmaceutical company that develops gene and cell therapies for life-threatening diseases in the United States. The company focuses on autologous and AAV-based approaches to treat rare inherited disorders, including ZEVASKYN, an autologous, cell-based gene therapy for recessive dystrophic epidermolysis bullosa, and ABO-503 to treat X-linked retinoschisis; ABO-504 for Stargardt disease; and ABO-505 to treat autosomal dominant optic atrophy.
Abeona Therapeutics Inc. trades at $6.80 and has a market cap of $387.57M, with a market rank of 3260. These figures position the stock among smaller-cap biopharma peers, reflecting its commercial-stage status.
A major floor 39.4% below — a decisive break under it would weaken the trend.
The nearest floor, 23.2% below — buyers have tended to step in here.
Price is pressing into resistance (2.0% away) — a breakout level to watch.
A major ceiling 18.1% above — clearing it would confirm fresh momentum.
Key ABEO support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ABEO market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $6.75 | Buy | $6.78 | Buy |
| MA 10 | $6.37 | Buy | $6.49 | Buy |
| MA 20 | $6.01 | Buy | $6.17 | Buy |
| MA 50 | $5.76 | Buy | $5.80 | Buy |
| MA 100 | $5.37 | Buy | $5.56 | Buy |
| MA 200 | $5.23 | Buy | $5.47 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 72.67 | Sell |
| Stoch RSI (14) | 82.96 | Sell |
| CCI (20) | 149.49 | Buy |
| Williams %R (14) | -8.97 | Info |
| MACD (12,26,9) | 0.13 | Buy |
| ROC (12) | 22.03 | Buy |
| Bollinger %B (20,2) | 0.99 | Neutral |
| Stochastic %K (14) | 91.03 | Sell |
| TRIX (15) | 0.49 | Buy |
| Awesome (5,34) | 0.92 | Buy |
| Ultimate (7,14,28) | 74.66 | Sell |
| Momentum (10) | 1.42 | Buy |
| Aroon Osc (25) | 76.00 | Buy |
| Hull MA (9) | 7.13 | Sell |
| ADX (14) | 23.26 | Buy |
| ATR (14) | 0.16 | Info |
The 30-day technical picture is bullish with RSI14 at 70. The stock is trading above the 50-day simple moving average of $5.69 and the 200-day simple moving average of $5.21, signaling constructive momentum. Near term, support sits at $5.36 and resistance at $6.80, with a 30-day price range of $5.71 to $8.10.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.23 | $6.98 | $9.43 | 0% | Neutral | |
| $6.87 | $8.61 | $11.42 | +23% | Bullish | |
| $7.98 | $10.28 | $14.14 | +47% | Bullish | |
| $8.98 | $11.84 | $16.75 | +70% | Bullish | |
| $12.02 | $16.17 | $23.43 | +132% | Bullish | |
| $13.72 | $18.80 | $27.82 | +169% | Bullish | |
| $14.10 | $19.64 | $29.62 | +181% | Bullish | |
| $16.21 | $22.95 | $35.20 | +229% | Bullish | |
| $16.76 | $24.08 | $37.52 | +245% | Bullish | |
| $17.58 | $25.63 | $40.52 | +267% | Bullish | |
| $28.20 | $43.89 | $73.75 | +529% | Bullish | |
| $62.15 | $108.27 | $198.83 | +14.5x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $4.23 | $6.98 | $8.46 | +0.00% |
| August 2026 | $5.99 | $7.07 | $8.56 | +1.24% |
| September 2026 | $6.00 | $7.12 | $8.72 | +0.80% |
| October 2026 | $6.25 | $7.47 | $9.23 | +4.87% |
| November 2026 | $6.35 | $7.63 | $9.50 | +2.12% |
| December 2026 | $6.24 | $7.52 | $9.43 | -1.37% |
Click any year to see its month-by-month ABEO forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, ABEO could reach as high as $9.43, with a base case around $6.98 and support toward $4.23 — roughly 0% from $6.98. Price action looks broadly range-bound.
Expect ABEO to range from $6.87 to $11.42 through 2027. The $8.61 average target implies a +23% move from current prices. That is up +23% on the projected 2026 average. Buyers look set to stay in control over this stretch.
The ABEO price prediction for 2028 points to an average of $10.28 (low $7.98, high $14.14) — a potential gain of +47% on today's $6.98. Momentum favours further upside here.
In 2029, ABEO is projected to trade between $8.98 and $16.75, averaging $11.84 — a potential gain of +70% from today's $6.98. That is up +15% on the projected 2028 average. Buyers look set to stay in control over this stretch.
Abeona Therapeutics Inc.'s 2030 outlook centres on $16.17, within a $12.02 to $23.43 range. That is up +37% on the projected 2029 average. That marks a +132% change versus current levels. Momentum favours further upside here.
By 2031, ABEO could reach as high as $27.82, with a base case around $18.80 and support toward $13.72 — roughly +169% from $6.98. Buyers look set to stay in control over this stretch.
Expect ABEO to range from $14.10 to $29.62 through 2032. The $19.64 average target implies a +181% move from current prices. That is up +4% on the projected 2031 average. Momentum favours further upside here.
The ABEO price prediction for 2033 points to an average of $22.95 (low $16.21, high $35.20) — a potential gain of +229% on today's $6.98. Buyers look set to stay in control over this stretch.
In 2034, ABEO is projected to trade between $16.76 and $37.52, averaging $24.08 — a potential gain of +245% from today's $6.98. That is up +5% on the projected 2033 average. Momentum favours further upside here.
Abeona Therapeutics Inc.'s 2035 outlook centres on $25.63, within a $17.58 to $40.52 range. That is up +6% on the projected 2034 average. That marks a +267% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, ABEO could reach as high as $73.75, with a base case around $43.89 and support toward $28.20 — roughly +529% from $6.98. Momentum favours further upside here.
Expect ABEO to range from $62.15 to $198.83 through 2050. The $108.27 average target implies a +14.5x move from current prices. That is up +147% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in ABEO today (≈ 143.266476 ABEO) could be worth
$15,511.38
+$14,511.38 (+1451%) by 2050 · US Dollar
Based on the average projected ABEO price of $108.27 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ABEOwould be worth at today's price.
$1,000 invested in ABEO on Jul 10, 2025 (≈ 170.940174 ABEO) would be worth
$1,193.16
+$193.16 (+19.3%) today · 1.19× · US Dollar
Based on a ABEO entry price of $5.85 vs. today's $6.98.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $6.4 | $1,090.62 | +9.1% |
| 1 month ago | $5.36 | $1,302.24 | +30.2% |
| 3 months ago | $4.91 | $1,421.59 | +42.2% |
| 6 months ago | $5.1 | $1,368.63 | +36.9% |
| 1 year ago | $5.85 | $1,193.16 | +19.3% |
| All time (5.0y) ago | $34.5 | $202.32 | -79.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ABEO forecast.
Our base-case forecast reaches $14.00 around 2030.
Implied market cap at $14.00: $797.93M
The multi-year forecast shows a continued bullish trajectory. In 2026 the avg price is $6.80 with a min of $4.23 and max of $9.16 and 0% ROI. By 2027 the avg rises to $8.35 (min $6.66, max $11.05) with a 22.8% ROI, and by 2028 the avg is $9.89 (min $7.68, max $13.57) with a 45.4% ROI.
The forecast accelerates through 2029 ($11.31 avg, $66.4% ROI) and 2030 ($15.39 avg, $22.25 max, 126.3% ROI), then stays bullish through 2031–2035 with progressively higher averages and ROIs (2031 avg $17.79, ROI 161.7%; 2035 avg $23.96, ROI 252.4%). In 2040 the avg is $40.72 (max $68.16) with a 498.8% ROI, and in 2050 the avg reaches $99.44 (max $181.78) with a 1362.3% ROI. These figures imply a sustained uptrend, though they are estimates and not guaranteed.
Tap a question to reveal the answer.
2030: avg $15.39; min $11.47; max $22.25; ROI 126.3%; sentiment BULLISH.
The forecast shows a 2050 max of $181.78 and a 2050 avg of $99.44, with a 1362.3% ROI. This indicates the possibility of reaching or exceeding $100 on the higher end of the forecast by 2050, though not guaranteed.
Current price is $6.80 and market cap is $387.57M.
RSI14 is 70 with sentiment BULLISH. The SMA50 is $5.69 and the SMA200 is $5.21. Support is at $5.36 and resistance at $6.80, with a 30-day range of $5.71 to $8.10. Annualized volatility is 50%.
Avg $8.35; min $6.66; max $11.05; ROI 22.8%; sentiment BULLISH.
Abeona Therapeutics Inc. Community Discussion
0Share your Abeona Therapeutics Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.